Scotiabank raised the firm’s price target on INmune Bio (INMB) to $23 from $22 and keeps an Outperform rating on the shares. The company’s ...

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at $35 per month.  The Novo Nordisk settlement reached on Jan. 27 ...

California state senator Scott Wiener has introduced two bills, SB 40 and SB 41, to lower the cost of prescription drugs for ...

Novo Nordisk stock gains as it reports better-than-expected fourth-quarter 2024 results driven by strong sales of Diabetes ...

As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

President Donald Trump’s executive order on Day One of his administration to “deliver emergency price relief” doesn’t include ... The first effort at the direct negotiation capped insulin costs at $35 ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its ...

“That’s what you voted for.” “Donald Trump has cancelled the $35 a month Insulin cap,” tweeted one X user with nearly 200,000 followers. “Prices are expected to almost instantly go ...

Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for $35 per month.

“When we eat large portions or eat too frequently, we continually spike insulin levels, which can lead to insulin resistance over time. Insulin resistance is a key factor in the development of ...